Selegiline tablets

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Approval Status:

Approved January 1997

Specific Treatments:

Parkinson’s disease

Therapeutic Areas

General Information

Selegiline has been approved for the treatment of Parkinson's disease. Selegiline is a generic equivalent of Somerset’s Eldepryl tablets, a drug for the treatment of Parkinson’s disease. Other generic versions of this product have been introduced over the last several months.


[ Home | Discussions | Article Archives | Help | Submit your Site]

Copyright 1996 - 2014 by Gelber Associates All Rights Reserved.